Ocean Biomedical Stock Today

OCEAW Stock   0.02  0.01  20.15%   

Performance

Very Weak

 
Weak
 
Strong

Odds Of Distress

Very High

 
High
 
Low
Ocean Biomedical is selling for under 0.021 as of the 19th of March 2025; that is 20.15% down since the beginning of the trading day. The stock's lowest day price was 0.021. Ocean Biomedical has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 19th of March 2025. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
Category
Healthcare
Classification
Health Care
Ocean Biomedical is entity of United States. It is traded as Stock on NASDAQ exchange. More on Ocean Biomedical

Moving against Ocean Stock

  0.41DVAX Dynavax TechnologiesPairCorr
  0.36VALN Valneva SE ADRPairCorr
  0.34EQ EquilliumPairCorr

Ocean Stock Highlights

Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors)
Ocean Biomedical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Ocean Biomedical's financial leverage. It provides some insight into what part of Ocean Biomedical's total assets is financed by creditors.
Liquidity
Ocean Biomedical has accumulated 12.12 M in total debt. Note, when we think about Ocean Biomedical's use of debt, we should always consider it together with its cash and equity.

Other Cashflows From Financing Activities

62.92 Million
Ocean Biomedical (OCEAW) is traded on NASDAQ Exchange in USA. It is located in null and employs 9 people. Ocean Biomedical is listed under Biotechnology category by Fama And French industry classification. The company classifies itself under Biotechnology sector and is part of Health Care industry. Ocean Biomedical generates negative cash flow from operations
Check Ocean Biomedical Probability Of Bankruptcy

Ocean Biomedical Historical Income Statement

At this time, Ocean Biomedical's Depreciation And Amortization is fairly stable compared to the past year. Total Operating Expenses is likely to climb to about 16.9 M in 2025, whereas Selling General Administrative is likely to drop slightly above 10.4 M in 2025. View More Fundamentals

Ocean Stock Against Markets

Additional Tools for Ocean Stock Analysis

When running Ocean Biomedical's price analysis, check to measure Ocean Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocean Biomedical is operating at the current time. Most of Ocean Biomedical's value examination focuses on studying past and present price action to predict the probability of Ocean Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ocean Biomedical's price. Additionally, you may evaluate how the addition of Ocean Biomedical to your portfolios can decrease your overall portfolio volatility.